Skip to main content
KROMEK GROUP PLC logo

KROMEK GROUP PLC — Investor Relations & Filings

Ticker · KMK ISIN · GB00BD7V5D43 LEI · 213800VLHYXGHEX5VQ48 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2021-02-12 Regulatory Filings
Country GB United Kingdom
Listing IL KMK

About KROMEK GROUP PLC

https://www.kromek.com/

Kromek Group plc is a developer and manufacturer of advanced radiation detection solutions based on high-performance sensor materials, primarily Cadmium Zinc Telluride (CZT) and scintillation detectors. The company provides hardware, software, and components to original equipment manufacturers (OEMs) and end-users across the advanced imaging, civil nuclear, and security markets. Key applications include medical imaging systems (such as SPECT and photon-counting CT), industrial inspection, and CBRN (Chemical, Biological, Radiological, Nuclear) threat detection for homeland security, military, and civil nuclear sectors. The company's proprietary CZT manufacturing process enables the production of high-resolution, room-temperature semiconductor detectors that offer enhanced sensitivity and performance for imaging and radionuclide identification.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and explicitly states that the information is provided by 'RNS, the news service of the London Stock Exchange,' which is approved by the Financial Conduct Authority (FCA). The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a routine operational update related to trading mechanisms. This type of short, mandatory regulatory notification that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory announcement category.
2021-02-12 English
Placing and Open Offer to raise up to £13 million
Capital/Financing Update Classification · 95% confidence The document is an RNS announcement (indicated by 'RNS Number : 9523O') detailing a 'Firm Placing, Directors' Subscription and Open Offer to raise up to £13 million' and includes a 'Notice of General Meeting'. The core content revolves around a capital raising event (Placing and Open Offer) which requires shareholder approval via resolutions at a General Meeting. This combination of capital raising/financing activity and the announcement of a General Meeting points strongly towards a financing event that necessitates shareholder approval. The filing explicitly mentions the General Meeting notice and the associated resolutions needed for the share allotment. While it announces a General Meeting (which might suggest AGM-R or DVA), the primary driver and focus of the announcement is the capital raise (£13 million). This fits best under 'Capital/Financing Update' (CAP). However, since the document explicitly contains the 'Notice of General Meeting' and discusses resolutions to be voted on, it also has strong elements of a proxy/meeting document. Given the structure, which is a formal regulatory announcement (RNS) detailing a major financing contingent on a shareholder vote, 'CAP' is the most specific fit for the financial action, but 'RPA' or 'RNS' could also apply if it were just an announcement of a report. Since this is the substance of the financing and meeting notice itself, 'CAP' is chosen as the primary theme, although it is delivered via an RNS format. Given the explicit mention of 'Notice of General Meeting' and the need for shareholder approval, it is closely related to proxy materials, but the financial transaction is the main news. I will classify it as CAP, as it details the financing terms and the need for shareholder approval for that financing.
2021-02-12 English
Issue of Equity and Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange, indicated by the 'RNS Number' and the concluding boilerplate text. The content explicitly details the 'Issue of Equity and Total Voting Rights' following the exercise of employee options and the subsequent application for admission to trading of new ordinary shares. This directly relates to changes in the company's share capital structure. This fits the definition of 'Share Issue/Capital Change' (SHA). Although it is an RNS announcement, the specific subject matter (share issuance/capital change) is more precise than the general 'RNS' fallback category.
2021-02-04 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled as an 'RNS Number : 9723M' and contains the standard form 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of a Major Shareholding Notification. The content details the resulting percentage of voting rights (2.994%) after a threshold crossing on 26/1/21. This fits the 'MRQ' category (Major Shareholding Notification) better than the general 'RNS' fallback, as 'MRQ' is specifically defined for 'Notification of changes in significant share ownership levels (crossing thresholds)'.
2021-01-26 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number : 6656M' and contains information related to trading mechanisms on the London Stock Exchange, specifically mentioning a 'Second Price Monitoring Extension' and referencing RNS as the news service approved by the Financial Conduct Authority (FCA). This type of short, immediate regulatory notification that doesn't fit into specific financial reporting categories (like 10-K, ER, or IR) is best classified as a general Regulatory Filing, which corresponds to the RNS code.
2021-01-22 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1916 characters) and contains the header 'RNS Number : 6629M'. It announces a 'Price Monitoring Extension' related to trading procedures on the London Stock Exchange. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which is approved as a Primary Information Provider. This type of brief, procedural announcement that does not fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing or announcement, which corresponds to the RNS code.
2021-01-22 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.